Strata Skin Sciences, Inc.
SSKN
$2.59
-$0.03-1.15%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -111.92% | -2,043.43% | 97.06% | 11.23% | -260.30% |
| Total Depreciation and Amortization | -0.45% | -0.68% | -1.12% | -1.97% | -10.86% |
| Total Amortization of Deferred Charges | 0.00% | 0.00% | 25.81% | 10.71% | -3.45% |
| Total Other Non-Cash Items | 14,864.00% | -121.74% | -67.14% | -86.35% | 752.16% |
| Change in Net Operating Assets | -67.90% | 161.29% | -194.52% | -30.14% | 142.36% |
| Cash from Operations | 332.78% | -151.10% | 173.51% | -158.64% | 167.87% |
| Capital Expenditure | -712.90% | 82.03% | 52.41% | 57.80% | -985.57% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -712.90% | 82.03% | 52.41% | 57.80% | -985.57% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | -- | 100.00% |
| Cash from Financing | -100.00% | -- | 100.00% | -- | 100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -87.40% | 541.87% | 115.90% | -345.82% | 82.02% |